Oncologia

Estudo de base populacional sobre câncer colorretal: incidência, mortalidade, características do tumor e tratamento antes e depois da introdução do programa de rastreamento baseado em testes imunoquímicos fecais na Holanda.

13 Dez, 2021 | 11:26h

Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study – The Lancet Gastroenterology & Hepatology (link para o resumo – $ para o texto completo)

Comentário no Twitter

New research – Breekveldt et al – #Colorectalcancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the FIT-based #screening programme in the #Netherlands: a population-based studyhttps://t.co/nW9SVAhRxE #GITwitter #crcsm pic.twitter.com/GGRF9Az0tg

— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) November 23, 2021

Revisão | Câncer endometrial.

13 Dez, 2021 | 11:21h

Endometrial cancer – Nature Reviews Disease Primers (gratuito por tempo limitado – se o acesso a este link for pago, tente este)

Infográfico: Endometrial cancer (gratuito por tempo limitado – se o acesso a este link for pago, tente este)

Estudo randomizado de não inferioridade mostrou que a radioterapia pode ser seguramente omitida em muitas crianças e adolescentes em estágios intermediário e avançado de linfoma de Hodgkin clássico.

10 Dez, 2021 | 11:06h

Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial – The Lancet Oncology

Revisão sistemática | Benefícios e prejuízos do rastreamento mamográfico anual, bienal e trienal para mulheres na média de risco para câncer de mama.

9 Dez, 2021 | 15:20h

Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) – British Journal of Cancer

Comentário no Twitter (fio – clique para saber mais)

Our comprehensive #systematicreview for the #ECIBC on intervals (every 1, 2, 3 years) of #breastcancer #screening is available.
We included RCT, observational, and mathematical modeling studies to assess benefits and harms and applied the #GRADE approachhttps://t.co/IfplsWfKuA pic.twitter.com/7niEbnaWKR

— Carlos Canelo-Aybar (@ccaneloa) November 27, 2021

M-A | Eficácia e segurança associadas a inibidores do checkpoint imunológico no carcinoma hepatocelular irressecável.

8 Dez, 2021 | 12:58h

Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma: A Meta-analysis – JAMA Network Open

Comentário no Twitter

This meta-analysis of RCTs shows immune checkpoint inhibitors are associated with demonstrated the superior efficacy and safety of versus standard systemic therapies in patients with unresectable hepatocellular carcinoma. https://t.co/fJdFng69qH

— JAMA Network Open (@JAMANetworkOpen) December 6, 2021

Mesotelioma pleural maligno: Diretrizes de Prática Clínica da ESMO para diagnóstico, tratamento e seguimento.

8 Dez, 2021 | 12:57h

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up – Annals of Oncology

Atualização das Diretrizes de Prática Clínica da ESMO para uso de imunoterapia no estágio inicial ou avançado do carcinoma de células renais.

8 Dez, 2021 | 12:56h

ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma – Annals of Oncology

Farmacologia clínica de medicamentos citotóxicos em neonatos e crianças: orientação de doses baseada em evidências.

7 Dez, 2021 | 11:34h

Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance – European Journal of Cancer

Revisão | Passado, presente e futuro da cardiotoxicidade induzida por radiação.

6 Dez, 2021 | 16:13h

Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification – JACC: CardioOncology

Vídeo: Radiation Therapy and Cardiovascular Disease | JACC: CardioOncology Author Discussion

Conteúdos relacionados:

Cohort Study: Women treated with radiation therapy for left-sided breast cancer had over twice the risk of subsequent coronary artery disease compared with women treated with radiation therapy for right-sided breast cancer.

Radiation‐induced cardiovascular disease: review of an underrecognized pathology.

Short review: How to diagnose and manage radiation therapy cardiotoxicity

Cohort Study: Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients with Lung Cancer

O impacto global do câncer em adolescentes e jovens adultos em 2019: análise sistemática para o Global Burden of Disease Study 2019.

6 Dez, 2021 | 16:02h

The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 – The Lancet Oncology

Comentário convidado: Burden of cancer in adolescents and young adults – The Lancet Oncology